Clinical Trial Update: Human Bioequivalence Study of Amphotericin B Liposome for Injection [NA]

View source ↗

Summary

Completed a human bioequivalence study of liposomal amphotericin B for injection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections
• Neutropenic Fever
• Visceral Leishmaniasis

Drugs mentioned

• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd | Conditions: Invasive Fungal Infections, Neutropenic Fever | NA | Status: COMPLETED